Pless Gesine
Institut für Physiologische Chemie, Universitätsklinikum Essen, Essen, Germany.
Methods Mol Biol. 2010;640:511-23. doi: 10.1007/978-1-60761-688-7_28.
A variety of bioartificial liver support systems were developed to replace some of the liver's function in case of liver failure. Those systems, in contrast to purely artificial systems, incorporate metabolically active cells to contribute synthetic and regulatory functions as well as detoxification. The selection of the ideal cell source and the design of more sophisticated bioreactors are the main issues in this field of research. Several systems were already introduced into clinical studies to prove their safety. This review briefly introduces a cross-section of experimental and clinically applied systems and tries to give an overview on the problems and limitations of bioartificial liver support.
人们开发了多种生物人工肝支持系统,以便在肝功能衰竭时替代肝脏的部分功能。与纯人工系统不同,这些系统纳入了具有代谢活性的细胞,以发挥合成、调节功能以及解毒作用。选择理想的细胞来源和设计更复杂的生物反应器是该研究领域的主要问题。已有几种系统被引入临床研究以证明其安全性。本文简要介绍了一系列实验性和临床应用的系统,并试图概述生物人工肝支持的问题和局限性。